chartexchange

DARE
Dare Bioscience, Inc. Common Stock
stockNASDAQ

At CloseNov 18, 2026 3:57:45 PM EST
0.45USD+4.918%(+0.02)295,378
Pre-marketNov 18, 2026 8:50:30 AM EST
0.459USD+6.993%(+0.03)
After-hoursNov 18, 2026 4:00:30 PM EST
0.45USD-0.022%(-0.00)
Loading…
Loading…
Healthcare
Biotechnology
HQ
San Diego, CA, USA
Previous Close
$0.43
Beta
1.33
52-Week High
$3.78 2026-05-05
52-Week Low
$0.42 2026-11-17
SMA 50
$0.71
SMA 200
$1.50
Avg. Vol 10D
209,675
Avg. Vol 30D
169,105
Avg. Vol 90D
425,314
Relative Vol
1.75
17.36M
1.1300%
2,356
Jul 1, 2024 · 1-for-12 (reverse)
DARE Profile

daré bioscience (nasdaq: dare) is a clinical-stage biopharmaceutical company committed to the advancement of innovative products for women's reproductive health. we are driven by a mission to identify, develop and bring to market a diverse portfolio of novel therapies that expand treatment options, improve outcomes and facilitate convenience for women. we are initially focused on the areas of contraception, vaginal health and fertility. our lead product candidate, ovaprene, is a non-hormonal, monthly contraceptive ring that is currently in clinical studies.

DARE Performance
PeriodPriceDateChangeBeta
1W0.642026-11-12-30.13%10.944
1M0.712026-10-19-36.25%2.240
3M0.822026-08-19-45.40%1.938
6M2.252026-05-19-80.00%1.777
1Y1.712025-11-19-73.68%1.330
2Y3.182024-11-19-85.85%—
5Y20.042021-11-19-97.75%0.891
DARE Stock Summary

Dare Bioscience, Inc. Common Stock (NASDAQ:DARE) stock price today is $0.45, and today's volume is 295,378. DARE is up 4.918% today. The 30 day average volume is 169,105. DARE market cap is $8.85M with 19.67M shares outstanding.